【 导读 】中泰证券 定增 获批，券商再融资悄然回暖 中国基金报记者 舍梨 耗时两年，中泰证券60亿元定增终于获批。 10月13日，中泰证券公告称，公司向特定对象发行不超过60亿元股票的申请，已获得中国证券监督管理委员会同意注册批复。 今年以来，券商再融资步伐明显加快。在业内人士看来，随着多家券商相继"补血"，行业整体资本实力与服务能力有望进一步提升。 10月13日晚间，中泰证券公告称，公司于10月13日收到中国证券监督管理委员会出具的《关于同意中泰证券股份有限公司向特定对象发行 股票注册的批复》。批复同意公司向特定对象发行股票，本次发行应严格按照报送上海证券交易所的申报文件和发行方案实施。 此次定增计划可追溯至两年前。2023年6月30日，中泰证券抛出60亿元定增计划，这也是该公司自2020年上市以来的首次股权再融资。该 议案原定于2024年10月9日到期，但公司决定将其有效期延长12个月，至2025年10月9日。 进入2025年，这一定增计划的推进节奏明显提速。5月28日，定增申请获上交所受理，9月5日顺利过会，9月15日提交注册，10月13日最 终获证监会批复。 根据此前中泰证券披露的募集说明书，60亿 ...

Core Points - Zhongtai Securities received approval from the China Securities Regulatory Commission for a specific stock issuance, allowing the company to raise up to 6 billion yuan [1] - The funds raised will be used entirely to increase the company's capital after deducting issuance costs [1] - Several other securities firms have also completed or announced similar capital increase plans this year, including Tianfeng Securities with 4 billion yuan, Nanjing Securities with 5 billion yuan, and Dongwu Securities with a proposed 6 billion yuan [1]

Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][8]. Summary by Sections Approval and Issuance - On October 13, Zhongtai Securities announced that it received the CSRC's approval for a stock issuance to specific investors, which must be executed according to the submitted documents and issuance plan [1]. - The approval is valid for 12 months from the date of registration [1]. Fundraising Details - The private placement will raise up to 6 billion yuan, with the number of shares issued not exceeding 30% of the company's total share capital prior to the issuance, equating to a maximum of 2.091 billion shares [3]. - The controlling shareholder, Zao Mining Group, is set to subscribe for 36.09% of the new shares, amounting to no more than 2.166 billion yuan [3]. Use of Proceeds - The funds raised will be allocated to six key areas, including: 1. Information technology and compliance risk control: up to 1.5 billion yuan 2. Alternative investment business: up to 1 billion yuan 3. Market-making business: up to 1 billion yuan 4. Purchase of government bonds and corporate bonds: up to 500 million yuan 5. Wealth management business: up to 500 million yuan 6. Debt repayment and operational capital: up to 1.5 billion yuan [4]. Historical Context - The plan for this private placement was initiated over two years ago, with the first proposal made on June 30, 2023, marking the company's first equity financing since its listing in 2020 [6]. - The proposal's validity was extended multiple times, with the latest extension allowing it to remain effective until July 14, 2026 [6][7]. Market Position and Strategy - Zhongtai Securities has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [7]. - The company views this fundraising as a necessary step to align with regulatory support for capital replenishment and to enhance its service capabilities for the real economy [6][7].

Core Viewpoint - Zhongke Fuhai Technology Co., Ltd., a "unicorn" in low-temperature equipment manufacturing, has filed for initial public offering (IPO) with the Beijing Securities Regulatory Bureau, with Zhongtai Securities as the advisory underwriter [1] Company Overview - Zhongke Fuhai was established in August 2016 in Beijing, leveraging decades of large-scale low-temperature engineering technology achievements led by two academicians from the Chinese Academy of Sciences [1] - The company provides advanced low-temperature equipment and new energy application system solutions [1] Shareholding Structure - As of October 10, 2025, the company has no controlling shareholder, with the combined actual controllers being the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Gong Linghui, and Gao Jinlin, holding a total of 37.03% of voting rights [1]

Core Points - Dongshan Precision has experienced a decline of 5.02% on October 14, with a stock price of 62.31 yuan per share and a total market capitalization of 114.13 billion yuan [1] - The company has seen a cumulative drop of 10.61% over the past four days [1] - Dongshan Precision specializes in precision sheet metal and casting manufacturing, flexible circuit board design, production, and sales, with its main revenue sources being electronic circuit products (65.23%), touch panels and LCD modules (17.98%), precision components (13.93%), LED display devices (1.69%), and others (1.17%) [1] Fund Holdings - Dongshan Precision is a significant holding in the fund managed by Zhongtai Securities Asset Management, specifically in the Zhongtai Xingrui Prosperity Growth Mixed A fund, which held 69,100 shares, accounting for 2.41% of the fund's net value [2] - The fund has incurred a floating loss of approximately 227,300 yuan today and a total floating loss of 538,300 yuan during the four-day decline [2] - The Zhongtai Xingrui Prosperity Growth Mixed A fund was established on July 18, 2023, with a current scale of 41.02 million yuan and has achieved a year-to-date return of 35.03% [2]

Group 1 - The core point of the news is that Sanmei Co., Ltd. experienced a 5% drop in stock price, reaching 57.36 CNY per share, with a trading volume of 821 million CNY and a turnover rate of 2.28%, resulting in a total market capitalization of 35.017 billion CNY [1] - Sanmei Co., Ltd. specializes in the research, production, and sales of fluorochemical products, including fluorocarbon chemicals and inorganic fluorine products, with the main revenue sources being refrigerants (85.55%), hydrogen fluoride (9.77%), foaming agents (3.46%), material sales (0.70%), by-product sales (0.27%), and others (0.25%) [1] Group 2 - From the perspective of fund holdings, one fund under Zhongtai Securities Asset Management has a significant position in Sanmei Co., Ltd., specifically the Zhongtai CSI 500 Index Enhanced A fund, which held 10,200 shares, accounting for 0.83% of the fund's net value, ranking as the sixth largest holding [2] - The Zhongtai CSI 500 Index Enhanced A fund has a total scale of 18.9286 million CNY and has achieved a year-to-date return of 25.27%, ranking 2174 out of 4220 in its category, with a one-year return of 29.46%, ranking 1939 out of 3857 [2]

来源|中访网 中泰证券此次定增的落地，并非个例，而是今年券业再融资"回暖"的缩影。此前一年多时间里，券商再 融资市场相对沉寂，但2024年以来，多家券商密集推进资本补充计划，形成明显的"补血"潮。6月23 日，天风证券顺利完成40亿元定增募资，为业务扩张提供资金支撑；9月29日，南京证券50亿元定增计 划获上交所审核通过，进入后续实施阶段；7月，东吴证券也公布60亿元定增预案，拟通过资本补充增 强综合竞争力。 从行业背景来看，券商密集"补血"既是自身发展需求，也顺应了监管导向与市场趋势。近年来，随着资 本市场改革深化，券商在财富管理、投资银行、资产管理等业务领域的竞争日趋激烈，而这些业务的开 展均需充足的资本金作为支撑。与此同时，监管层也持续支持证券公司通过合理方式补充资本，鼓励券 商更好地服务实体经济高质量发展。 对于中泰证券而言，此次定增的意义尤为特殊。据公司此前披露，上市后其主要依赖非股权方式融资， 导致负债规模相对较高，净资本补充受限，已形成一定的资本缺口。此次60亿元定增的落地，将有效缓 解这一问题——不仅能提升净资本规模，优化资本结构，还能为业务拓展提供充足资金，助力公司在券 业竞争中抢占更有利地 ...

点评：中泰证券60亿元定增获批，标志着券商行业"补血"进程加速。此举将显著提升其资本实力，为业 务扩张提供支撑，市场对其估值预期或重新评估。行业层面，多家券商再融资动作频频，显示板块整体 资本补充需求旺盛，头部效应或将强化。对股市而言，券商作为市场重要参与者，资本金增强有助于提 升市场活跃度，但短期内需关注资金分流效应及板块内部竞争格局变化。 NO.2国投证券董事长王苏望辞任总经理，廖笑非接棒 10月13日，国投证券发布公告称，公司董事长王苏望因职务调整辞任总经理，仅保留董事长及董事会专 业委员会相应职务。与此同时，公司正式聘任廖笑非为新任总经理，且国投证券官网已同步更新该信 息。作为深耕证券行业多年的"老兵"，廖笑非履历覆盖券商业务、监管及合规等多领域。回溯国投证券 近年发展，自2023年净利润跌至行业第26位后，管理层开启"大换血"，从王苏望代行总经理，到逐步完 成高管团队搭建。公司2024年业绩触底反弹，净利润同比增30.49%且行业排名上升9位，2025年上半年 净利润同比增长44.83%。如今廖笑非上任，能否延续公司业绩增长态势，接好这根关键的"接力棒"，成 为市场关注的焦点。 NO.3锦龙股份30 ...

Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of shares amounting to 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][5]. Group 1: Fundraising Details - The company plans to issue up to 2.091 billion shares, which is no more than 30% of its total share capital prior to the issuance [2]. - The controlling shareholder, Zhaomining Group, is set to subscribe for 36.09% of the new shares, amounting to a maximum of 2.166 billion yuan [2]. - The total funds raised will be used to enhance the company's capital base, optimize its business structure, and improve market competitiveness and risk resilience [2][4]. Group 2: Historical Context - The fundraising initiative was first proposed over two years ago, with the initial plan announced on June 30, 2023, marking the company's first equity financing since its listing in 2020 [3]. - The approval process involved multiple extensions and responses to regulatory inquiries, reflecting the complexities of the approval process [3][5]. - The company has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [4]. Group 3: Regulatory Approval Process - The CSRC's approval is valid for 12 months from the date of issuance, allowing the company to proceed with the share issuance within this timeframe [1]. - The Shanghai Stock Exchange had previously indicated that the company's application met the necessary conditions for issuance and listing [5].

Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][5]. Summary by Sections Approval and Issuance - On October 13, Zhongtai Securities announced that it received the CSRC's approval for the issuance of shares to specific investors, which is valid for 12 months from the date of approval [1]. - This marks a resurgence in the refinancing activities of securities firms, with other firms like Tianfeng Securities and Nanjing Securities also completing significant capital raises this year [1]. Fundraising Details - The private placement will involve issuing no more than 2.091 billion shares, accounting for up to 30% of the company's total shares prior to the issuance [3]. - The controlling shareholder, Zao Mining Group, is set to subscribe for 36.09% of the new shares, amounting to a maximum of 2.166 billion yuan [3]. Use of Proceeds - The total amount raised from the issuance will not exceed 6 billion yuan, and the funds will be allocated to various areas, including: - Information technology and compliance risk control: up to 1.5 billion yuan - Alternative investment business: up to 1 billion yuan - Market-making business: up to 1 billion yuan - Purchase of government and corporate bonds: up to 500 million yuan - Wealth management business: up to 500 million yuan - Debt repayment and other operational funding: up to 1.5 billion yuan [4]. Historical Context - The plan for this private placement was initiated over two years ago, with the first proposal made on June 30, 2023, marking the company's first equity financing since its listing in 2020 [5]. - The approval process involved multiple extensions and responses to regulatory inquiries, reflecting the complexities of the current market environment [5][6]. Capital Structure and Strategy - Zhongtai Securities has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [6]. - The company aims to address its capital shortfall through this issuance, aligning with regulatory support for securities firms to enhance their capital base and contribute to the high-quality development of the real economy [5][6].